Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-19

Clinical Trial Update: A Study To Estimate The Effects Of Food On Drug Fesoterodine Fumarate And The Pharmacokinetics Of 5-Hydroxymethyl Tolterodine (5-HMT) In Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating how food affects exposure to fesoterodine fumarate and the pharmacokinetics of its active metabolite 5-Hydroxymethyl tolterodine (5-HMT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Hydroxymethyl tolterodine (5-Hydroxymethyl tolterodine)
  • Fesoterodine fumarate (fesoterodine fumarate)

Snippet

Sponsor: Pfizer | Conditions: Urinary Bladder, Overactive | Phase 1 | Status: COMPLETED